Abstract

Fumonisins (FB1+FB2) and deoxynivalenol (DON) are mycotoxins produced by Fusarium species that might be present in maize and maize products. Knowledge on their occurrence in nixtamalized maize from Mexico together with an accompanying risk assessment are scarce, while nixtamalized maize is an important food in Mexico. This study presents the occurrence of FB1 + FB2 and DON in nixtamalized maize samples collected in Mexico City and analyses their distribution and resulting estimated daily intake for Mexican consumers by a probabilistic approach using a two-dimensional Monte-Carlo simulation. The results obtained reveal that for FB1 + FB2, 47% of the Mexican men and 30% of the Mexican women might exceed the provisional tolerable daily intake (PMTDI) of 2 µg/kg bw/day for fumonisins and for DON, 9% of men and 5% of women would be exceeding the PMTDI of 1 µg/kg bw/day, corresponding to the high consumers. The results raise a flag for risk managers in Mexico, to consider regulations and interventions that lower mycotoxin levels in nixtamalized maize for human consumption.

Highlights

  • Infection by Fusarium spp. is a common contamination occurring in maize, which can result in the production of different Fusarium toxins that may end up as food and feed contaminants [1]

  • Because consumption patterns play an important role in the ultimate exposure, information on the natural occurrence of fumonisins and other mycotoxins, like DON, from high consumption areas is important [6,20]

  • We present up-to-date occurrence data on fumonisin B1 (FB1), fumonisin B2 (FB2) and DON from 64 nixtamalized maize flour samples obtained on the Mexican market, quantified using LC–MS/MS

Read more

Summary

Introduction

Infection by Fusarium spp. is a common contamination occurring in maize, which can result in the production of different Fusarium toxins that may end up as food and feed contaminants [1]. Among the Fusarium toxins, the B-series fumonisins are the most prevalent mycotoxins in maize and its products. The B-series of the fumonisins are modified sphingoid bases mainly consisting of fumonisin B1 (FB1), fumonisin B2 (FB2) and fumonisin B3 (FB3) [2]. Evidence for adverse health effects of fumonisins in humans is limited, the main concern is their potential to contribute to cancer development through lipid metabolism disruption via the inhibition of ceramide synthase [2]. FB1 has been classified by the International Agency for Research on Cancer (IARC) as a group 2B agent, possibly carcinogenic to humans [4]. Based on liver toxicity in a short-term dose-response study in male transgenic mice with a Toxins 2020, 12, 644; doi:10.3390/toxins12100644 www.mdpi.com/journal/toxins

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call